이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

시뮬레이션 된 열파 중 노인의 생리적 변형에 대한 실내 습도의 영향

2026년 11월 9일 업데이트: Glen P. Kenny, University of Ottawa

권장 실내 온도 상한 26 ° C의 조정이 더 높은 수준의 습도 중에 필요합니까?

Laboratory-based studies show that exposure to high humidity can worsen the effects of heat stress in young and older adults by impeding sweat evaporation - the main mechanism by which the human body cools itself. At high levels of humidity, the efficiency of sweating decreases causing a greater rise core temperature and burden on the cardiovascular system. In this context, increasing temperatures and humidity with climate change thus pose a potential compound risk for human health. While humidity's role in heat-health outcomes could substantially alter projections of health burdens from climate change, the impact of humidity on physiological strain in vulnerable people in relation to the indoor environment has yet to be evaluated. In a recent study delineating the physiological effects of the proposed 26°C indoor upper limit (PMID: 38329752), relative humidity was set to 45% in all conditions based on indoor humidity standards by the American Society of Heating and Air-Conditioning Engineers. However, it is unknown whether a refinement of the recommended indoor temperature limit of 26°C is required in situations where humidity cannot be maintained at this level.

On separate occasions, the investigators will assess the change in body temperature and cardiovascular strain in older adults (65-85 years) exposed for 10 hours at the recommended indoor temperature limit of 26°C and 45% relative humidity (equivalent humidex of 29 (considered comfortable)) (experimental condition A), to 26°C with a relative humidity of 15% (equivalent humidex of 23 (considered comfortable); humidex is used to measure the perceived temperature taking into account the humidity)) (experimental condition B), to 26°C with a relative humidity of 85% (equivalent humidex of 37 (considered somewhat uncomfortable)) (experimental condition C), and to 31°C and 45% relative humidity with an equivalent humidex of 37 (considered somewhat uncomfortable) that is similar to experimental condition C. With this experimental design, investigators will assess the effects of indoor humidity in driving human heat strain and identify whether refinements in the recommended 26°C indoor temperature limit may be required. Further, by evaluating changes in relation to ambient conditions with a similar humidex, the investigators can assess how individuals perceive and respond to both heat and humidity.

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

연구 유형

중재적

등록 (추정된)

10

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Ontario
      • Ottawa, Ontario, 캐나다, K1N6N5
        • University of Ottawa

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

60년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Non-smoking.
  • English or French speaking.
  • Ability to provide informed consent.
  • with or without a) chronic hypertension (elevated resting blood pressure; as defined by Heart and Stroke Canada and Hypertension Canada), b) type 2 diabetes as defined by Diabetes Canada, with at least 5 years having elapsed since time of diagnosis

Exclusion Criteria:

  • Episode(s) of severe hypoglycemia (requiring the assistance of another person) within the previous year, or inability to sense hypoglycemia (hypoglycemia unawareness).
  • Serious complications related to diabetes (gastroparesis, renal disease, uncontrolled hypertension, severe autonomic neuropathy).
  • Uncontrolled hypertension - BP >150 mmHg systolic or >95 mmHg diastolic in a sitting position.
  • Restrictions in physical activity due to disease (e.g. intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
  • Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable.
  • Cardiac abnormalities identified during screening

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Exposure to recommended indoor temperature limit with normal indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 45% relative humidity (humidex equivalent of 29).

Older adults are exposed to a 10-hour simulated exposure

실험적: Exposure to recommended indoor temperature limit with low indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 15% relative humidity (humidex equivalent of 23).

Older adults are exposed to a 10-hour simulated exposure

실험적: Exposure to recommended indoor temperature limit with high indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 85% relative humidity (humidex equivalent of 37).

Older adults are exposed to a 10-hour simulated exposure

실험적: Exposure to high indoor temperature with normal indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 31°C and 45% relative humidity (humidex equivalent of 37).

Older adults are exposed to a 10-hour simulated exposure

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Core temperature (Peak) during daylong exposure to indoor overheating
기간: End of 10 hour daylong exposure

Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the 10 hours of the simulated indoor overheating.

End of 10 hour daylong exposure
Core temperature (AUC) during daylong exposure to indoor overheating
기간: End of 10 hour daylong exposure

Areas under the curve (AUC) of rectal temperature during the 10 hour simulate indoor overheating.

End of 10 hour daylong exposure
Heat rate (Peak) during daylong exposure to indoor overheating
기간: End of 10 hour daylong exposure

Peak heart rate (15 min average) during exposure. Heart rate is measured continuously throughout the 10 hours of the simulated indoor overheating.

End of 10 hour daylong exposure
Heart rate (AUC) during daylong exposure to indoor overheating
기간: End of 10 hour daylong exposure

Areas under the curve (AUC) of heart rate during the 10 hour simulate indoor overheating.

End of 10 hour daylong exposure
Cardiac response to standing from supine (30:15 Ratio) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Systolic Response to Standing From Supine during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Heart rate variability: RMSSD during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Heart rate variability: SDNN during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Thermal comfort scale during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Thermal comfort assessed via a visual analog scale ranging from extremely uncomfortable to extremely comfortable (midpoint: neutral).

At the start (hour 0) and end of 10 hour daylong exposure
Thirst sensation scale during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Thermal sensation assessed via a visual analog scale ranging from extremely hot to neutral (midpoint: hot).

At the start (hour 0) and end of 10 hour daylong exposure
Arousal scale during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Felt arousal scale assessed via a visual analog scale ("How worked up are you?") ranging from "high arousal" to "low arousal".

At the start (hour 0) and end of 10 hour daylong exposure
Fluid loss during daylong exposure to indoor overheating
기간: At end of 10 hour daylong exposure

Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

At end of 10 hour daylong exposure
Changes in plasma volume during daylong exposure to indoor overheating
기간: At end of 10 hour daylong exposur

Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill

At end of 10 hour daylong exposur
Systolic blood pressure during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

At the start (hour 0) and end of 10 hour daylong exposure
Rate pressure product during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.

At the start (hour 0) and end of 10 hour daylong exposure

2차 결과 측정

결과 측정
측정값 설명
기간
Impulse control (cognitive function) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.

At the start (hour 0) and end of 10 hour daylong exposure
Memory recall (cognitive function) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.

At the start (hour 0) and end of 10 hour daylong exposure
CDC 4-Stage Balance Test (Postural stability) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).

At the start (hour 0) and end of 10 hour daylong exposure
BTrackS Balance Assessment (Postural stability) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

To assess postural stability, participants will be asked to stand on a BTracks force plate with their feet spread out to shoulder width, hand on their hips and eyes closed. The assessment will comprise of four trials (one practice trial) lasting 20 seconds in length and 20 seconds between trials. Center of pressure (COP) vector data along vertical (y) and horizontal (x) axes will be summed for the total path excursion length (cm) during each trial.

At the start (hour 0) and end of 10 hour daylong exposure
Profiles of Mood States (POMS) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem-related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives (reference). For each individual item, participants were asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) were summed to calculate its score.

At the start (hour 0) and end of 10 hour daylong exposure
Environmental Symptoms Questionnaire (ESQ) during daylong exposure to indoor overheating
기간: At the start (hour 0) and end of 10 hour daylong exposure

Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure [24, 25]. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score was calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake").

At the start (hour 0) and end of 10 hour daylong exposure
Sleepiness during daylong exposure to indoor overheating A
기간: At the start (hour 0) and end of 10 hour daylong exposure

Karolinska sleepiness scale measures the subjective level of sleepiness at a particular time

At the start (hour 0) and end of 10 hour daylong exposure
Sleepiness during daylong exposure to indoor overheating B
기간: At the start (hour 0) and end of 10 hour daylong exposure

Stanford sleepiness scale consists of only one item, where participant must identify one of seven statements that best represents their level of perceived sleepiness. It employs a scale of 1 to 7 with 1 = feeling wide awake and 7 = sleep onset soon

At the start (hour 0) and end of 10 hour daylong exposure

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 3월 14일

기본 완료 (실제)

2025년 11월 20일

연구 완료 (추정된)

2027년 9월 1일

연구 등록 날짜

최초 제출

2025년 2월 17일

QC 기준을 충족하는 최초 제출

2025년 2월 17일

처음 게시됨 (실제)

2025년 2월 24일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 9일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • HEPRU-2025-02-A

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .